Published in

American Academy of Neurology (AAN), Neurology, 18(74), p. 1477-1478, 2010

DOI: 10.1212/wnl.0b013e3181d8a414

American Academy of Neurology (AAN), Neurology, 23(73), p. 1957-1962, 2009

DOI: 10.1212/wnl.0b013e3181c5b46d

Elsevier, Year Book of Neurology and Neurosurgery, (2010), p. 39-40

DOI: 10.1016/s0513-5117(10)79238-3

Links

Tools

Export citation

Search in Google Scholar

Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Background: American Heart Association/American Stroke Association guidelines recommend initiating treatment with IV tissue plasminogen activator (tPA) in acute ischemic stroke patients without suspected coagulopathy prior to availability of clotting results; however, little or no data support this practice. We sought to identify how often blood clotting abnormalities were responsible for withholding IV tPA at our institution.